Literature DB >> 30236175

Closing the book on Category II: time for individualized regimens for patients with recurrent tuberculosis.

Sara C Auld1, Neel R Gandhi1, N Sarita Shah2.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 30236175      PMCID： PMC6385594          DOI： 10.5588/ijtld.18.0569

Source DB:  PubMed          Journal:  Int J Tuberc Lung Dis        ISSN： 1027-3719            Impact factor:   2.373


× No keyword cloud information.
  11 in total

1.  Eliminating the category II retreatment regimen from national tuberculosis programme guidelines: the Georgian experience.

Authors:  Jennifer Furin; Medea Gegia; Carole Mitnick; Michael Rich; Sonya Shin; Mercedes Becerra; Peter Drobac; Paul Farmer; Rocio Hurtado; J Keith Joseph; Salmaan Keshavjee; Iagor Kalandadze
Journal:  Bull World Health Organ       Date:  2011-11-24       Impact factor: 9.408

2.  Cost-effectiveness analysis of introduction of rapid, alternative methods to identify multidrug-resistant tuberculosis in middle-income countries.

Authors:  Carlos Acuna-Villaorduna; Anna Vassall; German Henostroza; Carlos Seas; Humberto Guerra; Lucy Vasquez; Nora Morcillo; Juan Saravia; Richard O'Brien; Mark D Perkins; Jane Cunningham; Luis Llanos-Zavalaga; Eduardo Gotuzzo
Journal:  Clin Infect Dis       Date:  2008-08-15       Impact factor: 9.079

3.  Direct tuberculosis drug susceptibility testing: time-saving and cost-effective in detecting MDR-TB.

Authors:  T Zhang; C-F Lv; J Wang; W-B Zheng; L-Z Lu; S-J Liu; J Bao
Journal:  Int J Tuberc Lung Dis       Date:  2016-03       Impact factor: 2.373

4.  Principles of IUATLD collaborative tuberculosis progammes.

Authors:  D A Enarson
Journal:  Bull Int Union Tuberc Lung Dis       Date:  1991-12

Review 5.  Treatment of multidrug-resistant tuberculosis.

Authors:  M D Iseman
Journal:  N Engl J Med       Date:  1993-09-09       Impact factor: 91.245

6.  Treatment of Tuberculosis. A Historical Perspective.

Authors:  John F Murray; Dean E Schraufnagel; Philip C Hopewell
Journal:  Ann Am Thorac Soc       Date:  2015-12

7.  Clinical trial of six-month and four-month regimens of chemotherapy in the treatment of pulmonary tuberculosis.

Authors: 
Journal:  Am Rev Respir Dis       Date:  1979-04

Review 8.  The answer is 17 years, what is the question: understanding time lags in translational research.

Authors:  Zoë Slote Morris; Steven Wooding; Jonathan Grant
Journal:  J R Soc Med       Date:  2011-12       Impact factor: 5.344

9.  Cost-effectiveness of treating multidrug-resistant tuberculosis.

Authors:  Stephen C Resch; Joshua A Salomon; Megan Murray; Milton C Weinstein
Journal:  PLoS Med       Date:  2006-07       Impact factor: 11.069

10.  A systematic review of clinical outcomes on the WHO Category II retreatment regimen for tuberculosis.

Authors:  D B Cohen; J Meghji; S B Squire
Journal:  Int J Tuberc Lung Dis       Date:  2018-10-01       Impact factor: 2.373
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.